130 related articles for article (PubMed ID: 32291590)
1. Reliability of fluorescein-assisted stereotactic brain biopsies in predicting conclusive tissue diagnosis.
Nevzati E; Chatain GP; Hoffman J; Kleinschmidt-DeMasters BK; Lillehei KO; Ormond DR
Acta Neurochir (Wien); 2020 Aug; 162(8):1941-1947. PubMed ID: 32291590
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the usefulness of fluorescein sodium fluorescence in stereotactic brain biopsy.
Thien A; Han JX; Kumar K; Ng YP; Rao JP; Ng WH; King NKK
Acta Neurochir (Wien); 2018 Feb; 160(2):317-324. PubMed ID: 29275519
[TBL] [Abstract][Full Text] [Related]
3. The Fluoropen: a simple low-cost device to detect intraoperative fluorescein fluorescence in stereotactic needle biopsy of brain tumors.
Thien A; Rao JP; Ng WH; King NK
Acta Neurochir (Wien); 2017 Feb; 159(2):371-375. PubMed ID: 27943078
[TBL] [Abstract][Full Text] [Related]
4. Fluorescein sodium fluorescence: role in stereotactic brain biopsy.
Singh DK; Khan KA; Singh AK; Kaif M; Yadav K; Kumar Singh R; Ahmad F
Br J Neurosurg; 2023 Feb; 37(1):82-85. PubMed ID: 34927514
[TBL] [Abstract][Full Text] [Related]
5. Use of intraoperative fluorescein sodium fluorescence to improve the accuracy of tissue diagnosis during stereotactic needle biopsy of high-grade gliomas.
Rey-Dios R; Hattab EM; Cohen-Gadol AA
Acta Neurochir (Wien); 2014 Jun; 156(6):1071-5; discussion 1075. PubMed ID: 24770732
[TBL] [Abstract][Full Text] [Related]
6. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
Diaz RJ; Dios RR; Hattab EM; Burrell K; Rakopoulos P; Sabha N; Hawkins C; Zadeh G; Rutka JT; Cohen-Gadol AA
J Neurosurg; 2015 Jun; 122(6):1360-9. PubMed ID: 25839919
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence-guidance in non-Gadolinium enhancing, but FET-PET positive gliomas.
Schebesch KM; Brawanski A; Doenitz C; Rosengarth K; Proescholdt M; Riemenschneider MJ; Grosse J; Hellwig D; Höhne J
Clin Neurol Neurosurg; 2018 Sep; 172():177-182. PubMed ID: 30032095
[TBL] [Abstract][Full Text] [Related]
8. Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI.
Lin FH; Zhang XH; Zhang J; He ZQ; Duan H; Ke C; Sai K; Jiang XB; Al-Nahari F; Xi SY; Mou YG
J Neurooncol; 2018 Sep; 139(3):757-765. PubMed ID: 30117022
[TBL] [Abstract][Full Text] [Related]
9. Fluorescein-assisted stereotactic needle biopsy of brain tumors: a single-center experience and systematic review.
Catapano G; Sgulò FG; Seneca V; Iorio G; de Notaris M; di Nuzzo G
Neurosurg Rev; 2019 Jun; 42(2):309-318. PubMed ID: 29383601
[TBL] [Abstract][Full Text] [Related]
10. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
Neira JA; Ung TH; Sims JS; Malone HR; Chow DS; Samanamud JL; Zanazzi GJ; Guo X; Bowden SG; Zhao B; Sheth SA; McKhann GM; Sisti MB; Canoll P; D'Amico RS; Bruce JN
J Neurosurg; 2017 Jul; 127(1):111-122. PubMed ID: 27715437
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative Molecular Imaging with Second Window Indocyanine Green Facilitates Confirmation of Contrast-Enhancing Tissue During Intracranial Stereotactic Needle Biopsy: A Case Series.
Li C; Sullivan PZ; Cho S; Nasrallah MP; Buch L; Isaac Chen HC; Lee JYK
World Neurosurg; 2019 Jun; 126():e1211-e1218. PubMed ID: 30885869
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen.
Woodworth G; McGirt MJ; Samdani A; Garonzik I; Olivi A; Weingart JD
Neurol Res; 2005 Jun; 27(4):358-62. PubMed ID: 15949232
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Tumor Pathology with Fluorescein Uptake and MRI Contrast-Enhancement in Stereotactic Biopsies.
Xu R; Rösler J; Teich W; Radke J; Früh A; Scherschinski L; Onken J; Vajkoczy P; Misch M; Faust K
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743401
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of fusion of metabolic and structural images for stereotactic biopsy of brain tumors without enhancement after contrast medium injection.
Todeschi J; Bund C; Cebula H; Chibbaro S; Lhermitte B; Pin Y; Lefebvre F; Namer IJ; Proust F
Neurochirurgie; 2019 Dec; 65(6):357-364. PubMed ID: 31560911
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
[No Abstract] [Full Text] [Related]
16. MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen.
McGirt MJ; Villavicencio AT; Bulsara KR; Friedman AH
Surg Neurol; 2003 Apr; 59(4):277-81; discussion 281-2. PubMed ID: 12748009
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Magnetic Resonance Spectroscopy Compared with Stereotactic Biopsy of Intra-axial Brain Lesions.
Abdelaziz O; Eshra M; Belal A; Elshafei M
J Neurol Surg A Cent Eur Neurosurg; 2016 Jul; 77(4):283-90. PubMed ID: 26935295
[TBL] [Abstract][Full Text] [Related]
18. DCE-MRI in Human Gliomas: A Surrogate for Assessment of Invasive Hypoxia Marker HIF-1Α Based on MRI-Neuronavigation Stereotactic Biopsies.
Xie Q; Wu J; Du Z; Di N; Yan R; Pang H; Jin T; Zhang H; Wu Y; Zhang Y; Yao Z; Feng X
Acad Radiol; 2019 Feb; 26(2):179-187. PubMed ID: 29754996
[TBL] [Abstract][Full Text] [Related]
19. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients.
Kiesel B; Millesi M; Woehrer A; Furtner J; Bavand A; Roetzer T; Mischkulnig M; Wolfsberger S; Preusser M; Knosp E; Widhalm G
Neurosurg Focus; 2018 Jun; 44(6):E7. PubMed ID: 29852770
[TBL] [Abstract][Full Text] [Related]
20. Fluorescein-Guided Surgery for Resection of High-Grade Gliomas: A Multicentric Prospective Phase II Study (FLUOGLIO).
Acerbi F; Broggi M; Schebesch KM; Höhne J; Cavallo C; De Laurentis C; Eoli M; Anghileri E; Servida M; Boffano C; Pollo B; Schiariti M; Visintini S; Montomoli C; Bosio L; La Corte E; Broggi G; Brawanski A; Ferroli P
Clin Cancer Res; 2018 Jan; 24(1):52-61. PubMed ID: 29018053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
